Related references
Note: Only part of the references are listed.Re-examination of the dimerization state of leucine-rich repeat kinase 2: predominance of the monomeric form
Genta Ito et al.
BIOCHEMICAL JOURNAL (2012)
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
Iakov N Rudenko et al.
BMC Medicine (2012)
Impact of inter-subunit interactions on the dimeric arginine kinase activity and structural stability
Qing-Yun Wu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Mechanism of Kinase Inactivation and Nonbinding of FRATide to GSK3β Due to K85M Mutation: Molecular Dynamics Simulation and Normal Mode Analysis
ShaoYong Lu et al.
BIOPOLYMERS (2011)
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
Veronique Daniels et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Milestones in Parkinson's Disease-Clinical and Pathologic Features
Glenda Halliday et al.
MOVEMENT DISORDERS (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
Xianting Li et al.
PLOS ONE (2011)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
Zdenek Berger et al.
BIOCHEMISTRY (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Structural and Functional Consequences of the Substitution of Glycine 65 with Arginine in the N-Lobe of Human Transferrin
Anne B. Mason et al.
BIOCHEMISTRY (2009)
The R1441C mutation alters the folding properties of the ROC domain of LRRK2
Yongchao Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
Christian L. Klein et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With α-Synuclein Inclusions
Elisa A. Waxman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Regulation of LRRK2 Stability by the E3 Ubiquitin Ligase CHIP
Xiaodong Ding et al.
PLOS ONE (2009)
The WD40 Domain Is Required for LRRK2 Neurotoxicity
Nathan D. Jorgensen et al.
PLOS ONE (2009)
Clinical features of LRRK2 parkinsonism
Kristoffer Haugarvoll et al.
PARKINSONISM & RELATED DISORDERS (2009)
CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity
Han Seok Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
Elisa Greggio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2
Lizhen Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Patrick A. Lewis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Leucine-Rich Repeat kinase 2 G238SR variant is a risk factor for Parkinson disease in Asian population
Manabu Funayama et al.
NEUROREPORT (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan
Hon-Chung Fung et al.
BMC NEUROLOGY (2006)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
LRRK2 in Parkinson's disease: protein domains and functional insights
Ignacio F. Mata et al.
TRENDS IN NEUROSCIENCES (2006)
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
NATURE REVIEWS GENETICS (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Share Paper
